Head-to-head comparison of the incremental value of the three established risk markers hs-troponin I, hs-C-reactive protein and NT-proBNP in secondary prevention of coronary artery disease
Julius Nikorowitsch(University Hospital Schleswig-Holstein), Hakkı Muammer Karakaş, Tanja Zeller(Universität Hamburg), Francisco Ojeda(Universidad Complutense de Madrid), Renate B. Schnabel(Universität Hamburg), Stefan Blankenberg(Universität Hamburg), K Lackner(Johannes Gutenberg University Mainz)
Cited by 0
Related Papers
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Epidemiology of Atrial Fibrillation in the 21st Century
|Circulation Research|2020|1.5k
New loci associated with kidney function and chronic kidney disease
|Nature Genetics|2010|809